Avoid pitfalls when investing in Africa

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Avoid pitfalls when investing in Africa

With investment in Africa growing, IP protection in the region is key. Two sessions this week will provide some guidance for rights owners, explains James Nurton.

Foreign direct investment into Africa rose by 4% to $57 billion in 2013, according to data published by UNCTAD last year. With that figure expected to rise in the coming years, IP owners will become increasingly focused on protection in the region.

“Foreign investment is very much connected with intellectual property because investors will not come into a region where their rights are not adequately protected,” says Uche Nwokocha of Aluko & Oyebode in Lagos, Nigeria, who is moderating today’s regional update on Africa.

The session will cover different parts of the continent, with speakers from South Africa, Nigeria and Kenya. Nwokocha told the INTA Daily News: “These represent the different regions of Africa—sub-Saharan, west Africa (including Nigeria and Ghana) and east Africa.”

The session will focus in particular on the issues that arise when there are different agencies involved in IP protection; for example, dealing with trademarks, company names and food and drug approval.

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) works “hand-in-hand” with the trademark registry, as applicants for product approvals must show that they are a Nigerian-registered company and either the owner or assignee of the trademark they are intending to use, says Nwokocha.

Even though they are housed in different premises, she says, cross-reference between the two agencies takes place and trademark owners need to know what to expect: “NAFDAC will refer to the Trademark Registry to confirm that the acceptance was issued to the right person.”

Similar rules apply at the Companies Registry to ensure that applicants do not register a company name that infringes a registered trademark. “It’s not complicated,” says Nwokocha, “but you need to ensure you are not doing something that will go against the law of the land.”

She adds that getting your strategy in place ahead of investment is vital to ensure you know what to expect from the various agencies: “We will show you how they work hand-in-hand to ensure rights are adequately ­protected.”

RT20 Trademark Offices in Africa: The Importance of Working with Related Government Agencies takes place from 11:45 am to 1:00 pm today. It is followed by the Africa Reception from 1:15 pm to 2:15 pm. INTA will host a conference in Africa addressing many of these issues in 2016.

more from across site and SHARED ros bottom lb

More from across our site

Rebekah Gay discusses overcoming self-doubt, supporting the next generation of women lawyers, and how changing client demands are reshaping IP practice
New filing data suggests Germany's grip on UPC litigation remains strong, while Bardehle Pagenberg, Arnold Ruess, Hogan Lovells and Carpmaels notch up notable cases
In 27 years, KASS has expanded to seven countries in southeast Asia and is now eyeing further growth opportunities. Its CEO shares her perspective
Mine Güner discusses bridging law and business, taking the initiative, and why Taylor Swift helped put copyright on the map
Cindy Goh discusses why she launched Cheang & Ariff's IP department, the improving litigation environment in Malaysia and what to consider when using AI
Increased focus on adding patent litigation depth to the firm’s Dallas office was behind the boutique’s most recent hires
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gift this article